Next Article in Journal
Esters of the Marine-Derived Triterpene Sipholenol A Reverse P-GP-Mediated Drug Resistance
Next Article in Special Issue
Influence of Amino Acid Compositions and Peptide Profiles on Antioxidant Capacities of Two Protein Hydrolysates from Skipjack Tuna (Katsuwonus pelamis) Dark Muscle
Previous Article in Journal
Molecular and Chemical Analysis of the Lipopolysaccharide from Aeromonas hydrophila Strain AH-1 (Serotype O11)
Previous Article in Special Issue
Anti-Obesity Activity of the Marine Carotenoid Fucoxanthin
Article

Neuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson’s Disease

1
Department of Environmental Sciences, Faculty of Agriculture, Dalhousie University, P.O. Box 550, Truro, NS B2N 5E3, Canada
2
Aquatic and Crop Resource Development, National Research Council Canada, 1411 Oxford Street, Halifax, NS B3H 3Z1, Canada
3
Acadian Seaplants Limited, 30 Brown Avenue, Dartmouth, NS B3B 1X8, Canada
*
Author to whom correspondence should be addressed.
Academic Editor: Colin Barrow
Mar. Drugs 2015, 13(4), 2250-2266; https://doi.org/10.3390/md13042250
Received: 30 January 2015 / Revised: 30 March 2015 / Accepted: 1 April 2015 / Published: 14 April 2015
(This article belongs to the Special Issue Marine Functional Food)
Parkinson’s disease (PD) is the second most common neurodegenerative disorder in the elderly people, currently with no cure. Its mechanisms are not well understood, thus studies targeting cause-directed therapy or prevention are needed. This study uses the transgenic Caenorhabditis elegans PD model. We demonstrated that dietary supplementation of the worms with an extract from the cultivated red seaweed Chondrus crispus decreased the accumulation of α-synulein and protected the worms from the neuronal toxin-, 6-OHDA, induced dopaminergic neurodegeneration. These effects were associated with a corrected slowness of movement. We also showed that the enhancement of oxidative stress tolerance and an up-regulation of the stress response genes, sod-3 and skn-1, may have served as the molecular mechanism for the C. crispus-extract-mediated protection against PD pathology. Altogether, apart from its potential as a functional food, the tested red seaweed, C. crispus, might find promising pharmaceutical applications for the development of potential novel anti-neurodegenerative drugs for humans. View Full-Text
Keywords: Chondrus crispus; neuroprotective effect; oxidative stress; Parkinson’s disease Chondrus crispus; neuroprotective effect; oxidative stress; Parkinson’s disease
Show Figures

Figure 1

MDPI and ACS Style

Liu, J.; Banskota, A.H.; Critchley, A.T.; Hafting, J.; Prithiviraj, B. Neuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson’s Disease. Mar. Drugs 2015, 13, 2250-2266. https://doi.org/10.3390/md13042250

AMA Style

Liu J, Banskota AH, Critchley AT, Hafting J, Prithiviraj B. Neuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson’s Disease. Marine Drugs. 2015; 13(4):2250-2266. https://doi.org/10.3390/md13042250

Chicago/Turabian Style

Liu, Jinghua, Arjun H. Banskota, Alan T. Critchley, Jeff Hafting, and Balakrishnan Prithiviraj. 2015. "Neuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson’s Disease" Marine Drugs 13, no. 4: 2250-2266. https://doi.org/10.3390/md13042250

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop